VR Holdings, Inc. Enters Investment Banking Agreement With Delaney Equity Group, LLC.

CHESTERTOWN, Md. - June 7, 2013 - PRLog -- VR Holdings, Inc. announced today that it has signed an investment banking agreement with Delaney Equity Group, LLC.
Delaney Equity Group, LLC , based in Palm Beach Gardens, Fla., is a boutique broker dealer and market making firm specializing in trading Over the Counter, U.S. listed equities for a select group of hedge funds, professional traders, accredited investors and financial institutions. Delaney Equity Group possesses extensive experience in executing large trades in thin markets with minimal impact and is recognized for providing clients with superior executions, premier trading tools and support and exceptional client service. Delaney Equity Capital Group will also be providing services to VR Holdings, Inc., such as advising on the formation and implementation of corporate goals, the financial structure of the Company, reviewing possible joint ventures and/or merger and acquisition candidates, and attending and giving presentations at investor road shows.  
About VR Holdings, Inc.:

VR Holdings is, it believes, the only US corporation to go public with its major asset being a claim in a lawsuit. VR Holdings has filed and is proceeding with a $2 billion legal action against Cerberus Capital Management L.P., Madeleine, LLC, Gordon Brothers Group, Warren Feder and Stephen A. Feinberg. The lawsuit originally filed in 2007 by The Cancer Foundation, Inc., a 501(c)(3) charitable organization, and a shareholder of VR Holdings, Inc., included more than 20 plaintiffs, including MML, Inc., and Morton M. Lapides, Sr.  The suit charged that Cerberus, Gordon (now a subsidiary of Bank of America) and others, caused actions that prevented a $75 million donation to Johns Hopkins Hospital in Baltimore, Maryland, to expand the development of an immunization program to treat pancreatic cancer.

The Cancer Foundation, Inc., a large claimant, planned to donate $75 million of the VR Holdings donation to Johns Hopkins Hospital in Baltimore, Maryland for pancreatic cancer research. It investigated why funds were not forthcoming, and discovered that there were other claimants, mostly senior citizens, that were also damaged by the actions of two lenders to several VRH subsidiaries. The Chief Financial Officer of one of the VRH subsidiaries allegedly admitted to being bribed by the lenders. The Cancer Foundation with 22 other plaintiffs commenced litigation against the lenders in 1997, which is now in Illinois State Court. VR Holdings’   S-1 registration statement describes its business plan and the opportunity for claimants to exchange their claims for VR Holdings stock.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipates” or similar expressions.  Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.  Certain risks are detailed in the Company’s Form 10-K and other periodic filings with the Securities Exchange Commission at www.sec.gov.  This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sales of securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.